Skip to Content
 

News: Research

The plus and minus of microtubules

Friday, September 6th, 2019

Understanding the dynamic regulation of cytoskeletal microtubules may suggest new ways to treat disorders ranging from Alzheimer’s disease to cancer.

Study backs genetic testing for all metastatic breast cancer patients

Friday, September 6th, 2019

Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.

Cancer susceptibility genes

Saturday, August 31st, 2019

Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations.

Colorectal cancer researchers receive SPORE funding

Saturday, August 31st, 2019

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

New prostate cancer treatment concept

Friday, August 30th, 2019

Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

A “rheostat” for cancer signals

Friday, August 30th, 2019

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

Pancreatic cancer clue

Friday, August 30th, 2019

Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.

Protein’s role in inflammation-related cancer studied

Friday, August 30th, 2019

Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.

Potential second-line melanoma treatment identified

Friday, August 30th, 2019

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

Next Page »